These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 34313325)

  • 1. Whole genome sequencing identifies rare germline variants enriched in cancer related genes in first degree relatives of familial pancreatic cancer patients.
    Tan M; Brusgaard K; Gerdes AM; Mortensen MB; Detlefsen S; Schaffalitzky de Muckadell OB; Joergensen MT
    Clin Genet; 2021 Nov; 100(5):551-562. PubMed ID: 34313325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive analysis of candidate genes in familial pancreatic cancer families reveals a high frequency of potentially pathogenic germline variants.
    Earl J; Galindo-Pumariño C; Encinas J; Barreto E; Castillo ME; Pachón V; Ferreiro R; Rodríguez-Garrote M; González-Martínez S; Ramon Y Cajal T; Diaz LR; Chirivella-Gonzalez I; Rodriguez M; de Castro EM; García-Seisdedos D; Muñoz G; Rosa JMR; Marquez M; Malats N; Carrato A
    EBioMedicine; 2020 Mar; 53():102675. PubMed ID: 32113160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
    Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history.
    Chaffee KG; Oberg AL; McWilliams RR; Majithia N; Allen BA; Kidd J; Singh N; Hartman AR; Wenstrup RJ; Petersen GM
    Genet Med; 2018 Jan; 20(1):119-127. PubMed ID: 28726808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDKN2A germline mutations in familial pancreatic cancer.
    Bartsch DK; Sina-Frey M; Lang S; Wild A; Gerdes B; Barth P; Kress R; Grützmann R; Colombo-Benkmann M; Ziegler A; Hahn SA; Rothmund M; Rieder H
    Ann Surg; 2002 Dec; 236(6):730-7. PubMed ID: 12454511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cohort profile and heritability assessment of familial pancreatic cancer: a nation-wide study.
    Tan M; Brusgaard K; Gerdes AM; Mortensen MB; Detlefsen S; Schaffalitzky de Muckadell OB; Joergensen MT
    Scand J Gastroenterol; 2021 Aug; 56(8):965-971. PubMed ID: 34165379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline mutations in Japanese familial pancreatic cancer patients.
    Takai E; Yachida S; Shimizu K; Furuse J; Kubo E; Ohmoto A; Suzuki M; Hruban RH; Okusaka T; Morizane C; Furukawa T
    Oncotarget; 2016 Nov; 7(45):74227-74235. PubMed ID: 27732944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer families.
    Slater EP; Langer P; Fendrich V; Habbe N; Chaloupka B; Matthäi E; Sina M; Hahn SA; Bartsch DK
    Fam Cancer; 2010 Sep; 9(3):335-43. PubMed ID: 20195775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial and sporadic pancreatic cancer share the same molecular pathogenesis.
    Norris AL; Roberts NJ; Jones S; Wheelan SJ; Papadopoulos N; Vogelstein B; Kinzler KW; Hruban RH; Klein AP; Eshleman JR
    Fam Cancer; 2015 Mar; 14(1):95-103. PubMed ID: 25240578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A region-based gene association study combined with a leave-one-out sensitivity analysis identifies SMG1 as a pancreatic cancer susceptibility gene.
    Wong C; Chen F; Alirezaie N; Wang Y; Cuggia A; Borgida A; Holter S; Lenko T; Domecq C; ; Petersen GM; Syngal S; Brand R; Rustgi AK; Cote ML; Stoffel E; Olson SH; Roberts NJ; Akbari MR; Majewski J; Klein AP; Greenwood CMT; Gallinger S; Zogopoulos G
    PLoS Genet; 2019 Aug; 15(8):e1008344. PubMed ID: 31469826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-exome Sequencing Reveals New Potential Susceptibility Genes for Japanese Familial Pancreatic Cancer.
    Takai E; Nakamura H; Chiku S; Kubo E; Ohmoto A; Totoki Y; Shibata T; Higuchi R; Yamamoto M; Furuse J; Shimizu K; Takahashi H; Morizane C; Furukawa T; Yachida S
    Ann Surg; 2022 Apr; 275(4):e652-e658. PubMed ID: 32826389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Prevalence of Founder Mutations among Individuals from Families with Familial Pancreatic Cancer Syndrome.
    Lener MR; Kashyap A; Kluźniak W; Cybulski C; Soluch A; Pietrzak S; Huzarski T; Gronwald J; Lubiński J
    Cancer Res Treat; 2017 Apr; 49(2):430-436. PubMed ID: 27488870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PALLD mutation in a European family conveys a stromal predisposition for familial pancreatic cancer.
    Liotta L; Lange S; Maurer HC; Olive KP; Braren R; Pfarr N; Burger S; Muckenhuber A; Jesinghaus M; Steiger K; Weichert W; Friess H; Schmid R; Algül H; Jost PJ; Ramser J; Fischer C; Quante AS; Reichert M; Quante M
    JCI Insight; 2021 Mar; 6(8):. PubMed ID: 33764904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer.
    Roberts NJ; Norris AL; Petersen GM; Bondy ML; Brand R; Gallinger S; Kurtz RC; Olson SH; Rustgi AK; Schwartz AG; Stoffel E; Syngal S; Zogopoulos G; Ali SZ; Axilbund J; Chaffee KG; Chen YC; Cote ML; Childs EJ; Douville C; Goes FS; Herman JM; Iacobuzio-Donahue C; Kramer M; Makohon-Moore A; McCombie RW; McMahon KW; Niknafs N; Parla J; Pirooznia M; Potash JB; Rhim AD; Smith AL; Wang Y; Wolfgang CL; Wood LD; Zandi PP; Goggins M; Karchin R; Eshleman JR; Papadopoulos N; Kinzler KW; Vogelstein B; Hruban RH; Klein AP
    Cancer Discov; 2016 Feb; 6(2):166-75. PubMed ID: 26658419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline sequence analysis of RABL3 in a large series of pancreatic ductal adenocarcinoma patients reveals no evidence of deleterious variants.
    Roberts NJ; Grant RC; Gallinger S; Klein AP;
    Genes Chromosomes Cancer; 2021 Aug; 60(8):559-564. PubMed ID: 33724601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Germline Sequence Variations Among Patients With Pancreatic Cancer in China.
    Yin L; Wei J; Lu Z; Huang S; Gao H; Chen J; Guo F; Tu M; Xiao B; Xi C; Zhang K; Li Q; Wu J; Gao W; Jiang K; Yu J; Miao Y
    JAMA Netw Open; 2022 Feb; 5(2):e2148721. PubMed ID: 35171259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRCA2 germline mutations in familial pancreatic carcinoma.
    Hahn SA; Greenhalf B; Ellis I; Sina-Frey M; Rieder H; Korte B; Gerdes B; Kress R; Ziegler A; Raeburn JA; Campra D; Grützmann R; Rehder H; Rothmund M; Schmiegel W; Neoptolemos JP; Bartsch DK
    J Natl Cancer Inst; 2003 Feb; 95(3):214-21. PubMed ID: 12569143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline genetic variability in pancreatic cancer risk and prognosis.
    Gentiluomo M; Canzian F; Nicolini A; Gemignani F; Landi S; Campa D
    Semin Cancer Biol; 2022 Feb; 79():105-131. PubMed ID: 32818625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of familial pancreatic cancer families with additional colorectal carcinoma.
    Lehman B; Matthäi E; Gercke N; Denzer UW; Figiel J; Hess T; Slater EP; Bartsch DK
    Fam Cancer; 2023 Jul; 22(3):323-330. PubMed ID: 36717525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The best linear unbiased prediction (BLUP) method as a tool to estimate the lifetime risk of pancreatic ductal adenocarcinoma in high-risk individuals with no known pathogenic germline variants.
    Cristina-Marianini-Rios ; Sanchez MEC; de Paredes AGG; Rodríguez M; Barreto E; López JV; Fuentes R; Beltrán MM; Sanjuanbenito A; Lobo E; Caminoa A; Ruz-Caracuel I; Durán SL; Olcina JRF; Blázquez J; Sequeros EV; Carrato A; Ávila JCM; Earl J
    Fam Cancer; 2024 Aug; 23(3):233-246. PubMed ID: 38780705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.